Literature DB >> 29313809

PARP1 facilitates EP300 recruitment to the promoters of the subset of RBL2-dependent genes.

Agnieszka Robaszkiewicz1, Ewelina Wiśnik2, Zsolt Regdon3, Kinga Chmielewska4, László Virág5.   

Abstract

Differentiation of human monocytes is associated with proliferation arrest resulting from activation of the inter alia retinoblastoma protein family of gene repressors, which target gene promoters in an E2F-dependent manner. To investigate RBL2 contribution to defining monocyte phenotype and function, we used primer libraries. We identified genes encoding two surface receptors (CXCR1 and IL17RE) and two TLR signaling mediators (CD86 and NFKB2) that are repressed by the RBL2-E2F4-HDAC1-BRM complex. Surprisingly, PARP1 co-regulated 24 out of the 28 identified genes controlled by RBL2. Upon RBL2 silencing, PARP1 was recruited to one subset of RBL2-dependent genes, represented by MAP2K6 and MAPK3. RBL2 silencing also restored PARP1 transcription. Gene promoters enriched in PARP1 were characterized by increased histone acetylation and the replacement of HDAC1 with EP300. While PARP1 was dispensable for HDAC1 dissociation, EP300 was found only at gene promoters enriched in PARP1. EP300 activated transcription of PARP1/RBL2 co-regulated genes, but not genes solely controlled by RBL2. DNA was a prerequisite to the formation of an immunoprecipitated PARP1-EP300 complex, suggesting that PARP1 enabled EP300 binding, which in turn activated gene transcription. Notably, PARP1 overexpression failed to overcome the inhibitory effect of RBL2 on MAP2K6 and MAPK3 transcription. The same interdependence was observed in proliferating cancer cells; the low abundance of RBL2 resulted in PARP1-mediated EP300 recruitment to promoters of the MAP2K6 and MAPK3 genes. We conclude that RBL2 may indirectly regulate transcription of some genes by controlling PARP1-mediated EP300 recruitment.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  E1A binding protein p300 (EP300); Monocytes; Poly(ADP-ribose) polymerase 1 (PARP1); Retinoblastoma transcriptional co-repressor like 2 (RBL2)

Year:  2017        PMID: 29313809     DOI: 10.1016/j.bbagrm.2017.12.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta Gene Regul Mech        ISSN: 1874-9399            Impact factor:   4.490


  5 in total

1.  Downregulation of PARP1 transcription by CDK4/6 inhibitors sensitizes human lung cancer cells to anticancer drug-induced death by impairing OGG1-dependent base excision repair.

Authors:  Dominika Tempka; Paulina Tokarz; Kinga Chmielewska; Magdalena Kluska; Julita Pietrzak; Żaneta Rygielska; László Virág; Agnieszka Robaszkiewicz
Journal:  Redox Biol       Date:  2017-12-29       Impact factor: 11.799

Review 2.  PARP1 promoter links cell cycle progression with adaptation to oxidative environment.

Authors:  Julita Pietrzak; Corinne M Spickett; Tomasz Płoszaj; László Virág; Agnieszka Robaszkiewicz
Journal:  Redox Biol       Date:  2018-06-02       Impact factor: 11.799

3.  Long non-coding RNA GAS5 inhibits DDP-resistance and tumor progression of epithelial ovarian cancer via GAS5-E2F4-PARP1-MAPK axis.

Authors:  Xiaoran Long; Keqi Song; Hao Hu; Qi Tian; Wenjing Wang; Qian Dong; Xia Yin; Wen Di
Journal:  J Exp Clin Cancer Res       Date:  2019-08-07

4.  PARP1 Co-Regulates EP300-BRG1-Dependent Transcription of Genes Involved in Breast Cancer Cell Proliferation and DNA Repair.

Authors:  Maciej Sobczak; Andrew R Pitt; Corinne M Spickett; Agnieszka Robaszkiewicz
Journal:  Cancers (Basel)       Date:  2019-10-11       Impact factor: 6.639

Review 5.  The Role of PARP1 in Monocyte and Macrophage Commitment and Specification: Future Perspectives and Limitations for the Treatment of Monocyte and Macrophage Relevant Diseases with PARP Inhibitors.

Authors:  Maciej Sobczak; Marharyta Zyma; Agnieszka Robaszkiewicz
Journal:  Cells       Date:  2020-09-06       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.